124 related articles for article (PubMed ID: 9663654)
1. Inhibition of naloxone-stimulated adrenocorticotropin release by alprazolam in myotonic dystrophy patients.
Joyner JM; Grice JE; Hockings GI; Torpy DJ; Crosbie GV; Walters MM; Jackson RV
J Neuroendocrinol; 1998 May; 10(5):391-5. PubMed ID: 9663654
[TBL] [Abstract][Full Text] [Related]
2. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
[TBL] [Abstract][Full Text] [Related]
3. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
[TBL] [Abstract][Full Text] [Related]
4. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.
Vicennati V; Ceroni L; Gagliardi L; Pagotto U; Gambineri A; Genghini S; Pasquali R
J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651
[TBL] [Abstract][Full Text] [Related]
5. Adrenocorticotropin hyperresponse to the corticotropin-releasing hormone-mediated stimulus of naloxone in patients with myotonic dystrophy.
Grice JE; Jackson RV; Hockings GI; Torpy DJ; Walters MM; Crosbie GV
J Clin Endocrinol Metab; 1995 Jan; 80(1):179-84. PubMed ID: 7829609
[TBL] [Abstract][Full Text] [Related]
6. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
Clin Exp Pharmacol Physiol; 1995; 22(6-7):441-3. PubMed ID: 8582096
[TBL] [Abstract][Full Text] [Related]
7. Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.
Buyalos RP; Jackson RV; Grice GI; Hockings GI; Torpy DJ; Fox LM; Boots LR; Azziz R
J Clin Endocrinol Metab; 1998 Sep; 83(9):3219-24. PubMed ID: 9745431
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
Inder WJ; Ellis MJ; Evans MJ; Donald RA
Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
[TBL] [Abstract][Full Text] [Related]
9. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
[TBL] [Abstract][Full Text] [Related]
10. Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans.
Grottoli S; Maccagno B; Ramunni J; Di Vito L; Giordano R; Gianotti L; DeStefanis S; Camanni F; Ghigo E; Arvat E
J Endocrinol Invest; 2002 May; 25(5):420-5. PubMed ID: 12035937
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans.
Arvat E; Maccagno B; Ramunni J; Di Vito L; Giordano R; Gianotti L; Broglio F; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1999 Aug; 84(8):2611-5. PubMed ID: 10443648
[TBL] [Abstract][Full Text] [Related]
12. Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis.
Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):421-3. PubMed ID: 9171947
[TBL] [Abstract][Full Text] [Related]
13. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses.
Alexander SL; Irvine CH
Endocrinology; 1995 Nov; 136(11):5139-47. PubMed ID: 7588252
[TBL] [Abstract][Full Text] [Related]
14. Altered hypothalamic-pituitary-adrenal axis responsiveness in myotonic dystrophy: in vivo evidence for abnormal dihydropyridine-insensitive calcium transport.
Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson RV
J Clin Endocrinol Metab; 1993 Jun; 76(6):1433-8. PubMed ID: 8388880
[TBL] [Abstract][Full Text] [Related]
15. Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans.
Arvat E; Maccagno B; Ramunni J; Di Vito L; Gianotti L; Broglio F; Benso A; Deghenghi R; Camanni F; Ghigo E
Neuroendocrinology; 1998 May; 67(5):310-6. PubMed ID: 9641612
[TBL] [Abstract][Full Text] [Related]
16. Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercise in man.
Coiro V; Volpi R; Casti A; Maffei ML; Stella A; Volta E; Chiodera P
Br J Clin Pharmacol; 2011 Jun; 71(6):951-5. PubMed ID: 21564163
[TBL] [Abstract][Full Text] [Related]
17. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
[TBL] [Abstract][Full Text] [Related]
18. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
[TBL] [Abstract][Full Text] [Related]
19. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.
Grottoli S; Giordano R; Maccagno B; Pellegrino M; Ghigo E; Arvat E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4616-20. PubMed ID: 12364444
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical inhibition by aspirin of naloxone-induced adrenocorticotropin secretion in myotonic dystrophy.
Hockings GI; Jackson RV; Grice JE; Crosbie GV; Walters MM; Torpy DJ; Jackson AJ
J Clin Endocrinol Metab; 1994 Jun; 78(6):1424-7. PubMed ID: 8200945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
